PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology, Zuyderland Medical Center, Heerlen, Limburg, The Netherlands sofiaramiro@gmail.com.\', \'Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.\', \'Department of Pulmonology, Zuyderland Medical Center, Heerlen, Limburg, The Netherlands.\', \'Rheumatology, Zuyderland Medical Center, Heerlen, Limburg, The Netherlands.\', \'Department of Intensive Care, Zuyderland Medical Center, Heerlen, Limburg, The Netherlands.\', \'Department of Internal Medicine, Zuyderland Medical Center, Heerlen, Limburg, The Netherlands.\', \'Department of Clinical Chemistry and Hematology, Zuyderland Medical Center, Heerlen, Limburg, The Netherlands.\', \'Department of Clinical Pharmacy, Pharmacology and Toxicology, Zuyderland Medical Center, Heerlen, Limburg, The Netherlands.\', \'Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2020-218479
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 32719045
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all